These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 11710686)
41. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294 [TBL] [Abstract][Full Text] [Related]
42. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma. de Souza Meyer EL; Dora JM; Wagner MS; Maia AL Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828 [TBL] [Abstract][Full Text] [Related]
43. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6. Rabban JT; Koerner FC; Lerwill MF Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976 [TBL] [Abstract][Full Text] [Related]
44. CK19 IS A USEFUL MARKER IN DISTINGUISHING FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA FROM BENIGN THYROID LESIONS WITH FOLLICULAR GROWTH PATTERN. Noroozinia F; Gheibi A; Ilkhanizadeh B; Abbasi A Acta Endocrinol (Buchar); 2016; 12(4):387-391. PubMed ID: 31149120 [TBL] [Abstract][Full Text] [Related]
45. Expression of D2-40 in adjunct diagnosis of papillary thyroid carcinoma. Wang SL; Li SH; Chen WT; Chai CY APMIS; 2007 Aug; 115(8):906-10. PubMed ID: 17696946 [TBL] [Abstract][Full Text] [Related]
46. Follicular thyroid lesions, elements that affect both diagnosis and prognosis. Zeiger MA; Dackiw AP J Surg Oncol; 2005 Mar; 89(3):108-13. PubMed ID: 15719377 [TBL] [Abstract][Full Text] [Related]
47. p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Reis-Filho JS; Preto A; Soares P; Ricardo S; Cameselle-Teijeiro J; Sobrinho-Simões M Mod Pathol; 2003 Jan; 16(1):43-8. PubMed ID: 12527712 [TBL] [Abstract][Full Text] [Related]
49. Can cytomorphology differentiate between benign nodules and tumors arising in Graves' disease? Anderson SR; Mandel S; LiVolsi VA; Gupta PK; Baloch ZW Diagn Cytopathol; 2004 Jul; 31(1):64-7. PubMed ID: 15236269 [TBL] [Abstract][Full Text] [Related]
50. Lectin histochemistry of papillary and follicular carcinoma of the thyroid gland. Sobrinho-Simões M; Damjanov I Arch Pathol Lab Med; 1986 Aug; 110(8):722-9. PubMed ID: 3089192 [TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm. Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649 [TBL] [Abstract][Full Text] [Related]
52. Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC). Nassar A; Gupta P; LiVolsi VA; Baloch Z Diagn Cytopathol; 2003 Nov; 29(5):243-5. PubMed ID: 14595788 [TBL] [Abstract][Full Text] [Related]
53. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122 [TBL] [Abstract][Full Text] [Related]
54. [Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry]. Guyétant S; Michalak S; Valo I; Saint-André JP Ann Pathol; 2003 Feb; 23(1):11-20. PubMed ID: 12743496 [TBL] [Abstract][Full Text] [Related]
55. Cytokeratin expression profiles in thyroid carcinomas. Lam KY; Lui MC; Lo CY Eur J Surg Oncol; 2001 Nov; 27(7):631-5. PubMed ID: 11669590 [TBL] [Abstract][Full Text] [Related]
56. The role of cytokeratin 19 in the differential diagnosis of true papillary carcinoma of thyroid and papillary carcinoma-like changes in Graves' disease. Erkiliç S; Koçer NE Endocr Pathol; 2005; 16(1):63-6. PubMed ID: 16000848 [TBL] [Abstract][Full Text] [Related]
57. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Rosen J; He M; Umbricht C; Alexander HR; Dackiw AP; Zeiger MA; Libutti SK Surgery; 2005 Dec; 138(6):1050-6; discussion 1056-7. PubMed ID: 16360390 [TBL] [Abstract][Full Text] [Related]
58. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27(kip1) in the differential diagnosis of thyroid nodules. Park YJ; Kwak SH; Kim DC; Kim H; Choe G; Park DJ; Jang HC; Park SH; Cho BY; Park SY J Korean Med Sci; 2007 Aug; 22(4):621-8. PubMed ID: 17728499 [TBL] [Abstract][Full Text] [Related]
59. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis. Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701 [TBL] [Abstract][Full Text] [Related]